Moreover, it exhibits a mutational signature more similar to FL (CREBBP, BCL2, KMT2D, MYC, EZH2 and FOXO1 mutations) than to DLBCL, NOS (GCB subtype) [143]. This evidence concerns the gene BCL2 and diffuse large B-cell lymphoma.